Cresco Labs (CRLBF) to Announce Earnings on Thursday

Cresco Labs (OTCMKTS:CRLBF) is expected to release its results before the market opens on Thursday, August 6th. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $166.1970 million for the quarter.

Cresco Labs (OTCMKTS:CRLBF) last released its quarterly earnings data on Friday, May 8th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.01). Cresco Labs had a negative return on equity of 17.98% and a negative net margin of 20.90%.The business had revenue of $151.32 million for the quarter, compared to analyst estimates of $148.58 million. On average, analysts expect Cresco Labs to post $-0 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Cresco Labs Trading Up 3.0%

CRLBF opened at $0.70 on Wednesday. The company has a debt-to-equity ratio of 1.78, a quick ratio of 1.41 and a current ratio of 2.51. Cresco Labs has a one year low of $0.59 and a one year high of $2.30. The company has a market cap of $351.98 million, a P/E ratio of -1.80 and a beta of 1.54. The business’s 50-day simple moving average is $0.79 and its 200-day simple moving average is $0.93.

Cresco Labs Company Profile

Cresco Labs is a vertically integrated, multi-state cannabis operator in the United States. The company engages in the cultivation, manufacturing and distribution of a broad range of cannabis products, including flower, pre-rolled joints, concentrates, vaporizers, edibles and tinctures. Cresco Labs’ operations span cultivation facilities, processing laboratories and a network of wholesale distribution centers that supply licensed dispensaries and retail outlets across key cannabis markets.

The company’s product portfolio is organized under several branded platforms, such as MÜV, Reserve and High Supply, each designed to address different segments of the adult-use and medical cannabis markets.